Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.
Yamada Y, Sato K, Sakamoto S, Tsujino T, Saito S, Nishimura K, Fukushima T, Nakamura K, Yoshikawa Y, Matsunaga T, Maenosono R, Kanesaka M, Arai T, Sazuka T, Imamura Y, Komura K, Mikami K, Nakamura K, Fukasawa S, Chiba K, Naya Y, Nagata M, Komaru A, Nakatsu H, Azuma H, Ichikawa T.
Yamada Y, et al. Among authors: fukasawa s.
Int J Clin Oncol. 2024 Dec 10. doi: 10.1007/s10147-024-02676-z. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 39656401